DROPSTAR multi dose
Levofloxacin (as Levofloxacin hemihydrate)
Topical treatment of bacterial external ocular infections
TOBRAMESON single dose
Tobramycin/ Dexamethasone phosphate
Treat certain eye conditions due to inflammation or injury
TOBRAMESON multi dose
Tobramycin /Dexamethasone phosphate
Treat certain eye conditions due to inflammation or injury
DEXALEVO DROP multi dose
Levofloxacin/Dexamethasone phosphate
Treat certain eye conditions due to inflammation or injury
Levofloxacin (as Levofloxacin hemihydrate) 5 mg/ml
Ampoule 3ml, 5ml, 10ml
Eye drops solution
Topical treatment of bacterial external ocular infections in patients
≥1 year of age caused by levofloxacin susceptible microorganisms
Posology
For all patients instil one to two drops in the affected eye(s) every two hours up to 8 times per day while awake for the first two days and then four times daily on days 3 through 5.
If different topical ocular medications are used concomitantly, at least a 15-minute interval is required between instillations.
The duration of treatment depends on the severity of the disorder and on the clinical and bacteriological course of infection. The usual treatment duration is 5 days.
Safety and efficacy in the treatment of corneal ulcer and ophthalmia neonatorum has not been established.
Use in the Elderly
No adjustment of dosage is required.
Paediatric population
The posology is the same in adults and children aged ≥1 year.
The safety and efficacy of Levofloxacin in children aged ≥1 year have been established.
Levofloxacin is not recommended for use in children below age 1 year due to a lack of data on safety and efficacy.
The safety and efficacy of Levofloxacin in children aged < 1 year have not yet been established.
No data are available.
Tobramycin (asTobramycin sulfate) 3 mg/ml
Dexamethasone phosphate (as
dexamethasone sodium phosphate) 1 mg/ml
Ampoule 0.4ml, 1ml
Single-dose ophthalmic
Prevention and treatment of inflammation and prevention of infection associated with cataract surgery in adults and children aged 2 years and older.
Adults:
One drop instilled into the conjunctival sac(s) every 4 to 6 hours while the patient is awake. During the initial 24 to 48 hours, the dosage may be increased to one drop every two hours while the patient is awake. Dosing should continue for 14 days not to exceed a maximum of 24 days. Frequency should be decreased gradually as warranted by improvement in clinical signs. Care should be taken not to discontinue therapy prematurely.
Use in the Elderly:
Clinical studies have indicated dosage modifications are not required for use in the elderly.
Paediatric population:
Drug may be used in children 2 years of age and older at the same dose as in adults.
Tobramycin (asTobramycin sulfate) 3 mg/ml
Dexamethasone phosphate (as
dexamethasone sodium phosphate) 1 mg/ml
Ampoule 3ml, 5ml, 10ml
Eye drops solution
Prevention and treatment of inflammation and prevention of infection associated with cataract surgery in adults and children aged 2 years and older.
Adults:
One drop instilled into the conjunctival sac(s) every 4 to 6 hours while the patient is awake. During the initial 24 to 48 hours, the dosage may be increased to one drop every two hours while the patient is awake. Dosing should continue for 14 days not to exceed a maximum of 24 days. Frequency should be decreased gradually as warranted by improvement in clinical signs. Care should be taken not to discontinue therapy prematurely.
Use in the Elderly:
Clinical studies have indicated dosage modifications are not required for use in the elderly.
Paediatric population:
TOBRAMESON may be used in children 2 years of age and older at the same dose as in adults.
The safety and efficacy in children younger than 2 years of age have not been established, and no data is available.
Use in hepatic and renal impairment:
TOBRAMESON has not been studied in these patient populations
Shake the bottle well before use. To prevent contamination of the dropper tip and suspension, care should be taken not to touch the eyelids, surrounding areas, or other surfaces with the dropper tip of the bottle. Keep the bottle tightly closed when not in use. After cap is removed, if tamper evident snap collar is loose, remove before using product.
Gently closing the eyelid (s) and nasolacrimal occlusion for at least 1 minute after instillation is recommended. This may reduce the systemic absorption of medicinal products administered via the ocular route and result in a decrease in systemic side effects.
In case of concomitant therapy with other topical ophthalmic medicinal products, an interval of 5 minutes should be allowed between successive applications.
Eye ointments should be administered last.
Levofloxacin (as Levofloxacin hemihydrate) 5mg/ml; Dexamethasone phosphate (as Dexamethasone sodium phosphate) 1mg/ml
Ampoule 3ml, 5ml, 10 ml
Eye drops solution
Indicated for:
+ Steroid-responsive inflammatory ocular conditions (for which a corticosteroid is indicated and where bacterial infection or a risk of bacterial ocular infection exists)
+ Post-operative inflammation and any other ocular inflammation associated with infection.
- Day 1 and 2: 1-2 drops/time into eyes each 2 hours, 8 times/day.
- From day 3 to 7: 1-2 drops/time each 4 hours, 4 times/day.
- The number of drops should be reduced gradually when there are improvements in clinical signs. Should not stop treatment too soon.
To avoid contamination of the tip of the vial and drug solution, do not let the tip touch the eyelid, the area around the eye or any object.
- After opening the lid, the first drop should be removed before each use.
DEXAMOXI single dose
Moxifloxacine/ Dexamethasone phosphate
Treat certain eye conditions due to inflammation or injury
DEXAMOXI multi dose
Moxifloxacin/ Dexamethasone phosphate
Treat certain eye conditions due to inflammation or injury
MOXIEYE single dose
Moxifloxacin (as Moxifloxacin hydrochloride)
Topical treatment of purulent bacterial conjunctivitis
MOXIEYE multi dose
Moxifloxacin (as Moxifloxacin hydrochloride)
Topical treatment of purulent bacterial conjunctivitis
Moxifloxacine (as moxifloxacin hydrochloride) 5 mg/ml Dexamethasone phosphate (as dexamethasone sodium phosphate) 1 mg/ml
Ampoule 0.4ml, 1ml
Single-dose ophthalmic
Indicated for:
+ Steroid-responsive inflammatory ocular conditions (for which a corticosteroid is indicated and where bacterial infection or a risk of bacterial ocular infection exists)
+ Post-operative inflammation and any other ocular inflammation
associated with infection.
- Prevention of inflammation and infection after eye surgery:
Medication into the eye surgery begins 1 day before surgery and lasts for another 15 days after surgery
- Cataract surgery:
1 drop / time x 4 times / day, drops immediately after surgery
- LASIK refractive surgery:
1 drop / time x 4 times / day, instill the medicine within 15 minutes after surgery.
- Eye infections caused by susceptible bacteria:
1 drop / time x 4 times / day, within 7 days or as directed by your doctor.
Moxifloxacine (as moxifloxacin hydrochloride) 5 mg/ml
Dexamethasone phosphate (as dexamethasone sodium phosphate) 1 mg/ml
Ampoule 2ml, 3ml, 5ml, 8ml, 10ml
Eye drops solution
Indicated for:
+ Steroid-responsive inflammatory ocular conditions (for which a corticosteroid is indicated and where bacterial infection or a risk of bacterial ocular infection exists)
+ Post-operative inflammation and any other ocular inflammation
associated with infection.
To prevent post-surgery ocular inflammation and infection, instill 1 drop 4 times per day in the eye to be operated, starting 1 day before the surgery and during 15 days after the surgery. In patients submitted to cataract surgery, instill the solution immediately after the surgery. In patients submitted to refractive surgery by LASIK, instill the solution within 15 minutes after the surgery.
In the ocular infections caused by susceptible organisms, instill 1 drop 4 times per day during 7 days, or as directed by the doctor.
Follow the doctor's instructions on the schedule, dose and duration of treatment. Do not discontinue treatment without consulting the doctor. Do not use outdated medicine. Observe the appearance of the medicine before using it.
To prevent contaminating the dropper tip and solution, care should be taken not to touch any surface with the dropper tip of the bottle.
FOR OCULAR USE ONLY. To prevent contamination of the dropper tip and solution, care must be taken not to touch the eyelids, surrounding areas or other surfaces with the dropper tip. Keep the bottle tightly closed when not in use. If the patient is using other eye drop or eye ointment medicines, leave at least 5 minutes between each medicine. Eye ointments should be administered last.
Moxifloxacin (as Moxifloxacin hydrochloride) 5 mg/ml
Ampoule 0.4 ml, 1ml
Single-dose ophthalmic
Topical treatment of purulent bacterial conjunctivitis, caused by moxifloxacin susceptible strains
For ocular use only. Not for injection. MOXIEYE, solution should not be injected subconjunctivally or introduced directly into the anterior chamber of the eye.
Use in adults including the elderly (≥ 65 years)
The dose is one drop in the affected eye(s) 3 times a day.
The infection normally improves within 5 days and treatment should then be continued for a further 23 days. If no improvement is observed within 5 days of initiating therapy, the diagnosis and/or treatment should be reconsidered. The duration of treatment depends on the severity of the disorder and on the clinical and bacteriological course of infection.
Paediatric patients
No dosage adjustment is necessary.
Use in hepatic and renal impairment No dosage adjustment is necessary.
To prevent contamination of the dropper tip and solution, care must be taken not to touch the eyelids, surrounding areas or other surfaces with the dropper tip of the bottle.
In order to prevent the drops from being absorbed via the nasal mucosa, particularly in newborn infants or children, the nasolacrimal ducts should be held closed for 2 to 3 minutes with the fingers after administering the drops. After cap is removed, if tamper evident snap collar is loose, remove before using the product.
If more than one topical ophthalmic medicinal product is being used, the medicinal products must be administered at least 5 minutes apart. Eye ointments should be administered last.
Moxifloxacin (as Moxifloxacin hydrochloride) 5 mg/ml
Ampoule 2ml, 3ml, 5ml, 10ml
Eye drops solution
Topical treatment of purulent bacterial conjunctivitis, caused by moxifloxacin susceptible strains
For ocular use only. Not for injection. MOXIEYE, solution should not be injected subconjunctivally or introduced directly into the anterior chamber of the eye.
Use in adults including the elderly (≥ 65 years)
The dose is one drop in the affected eye(s) 3 times a day.
The infection normally improves within 5 days and treatment should then be continued for a further 23 days. If no improvement is observed within 5 days of initiating therapy, the diagnosis and/or treatment should be reconsidered. The duration of treatment depends on the severity of the disorder and on the clinical and bacteriological course of infection.
Paediatric patients
No dosage adjustment is necessary.
Use in hepatic and renal impairment No dosage adjustment is necessary.
To prevent contamination of the dropper tip and solution, care must be taken not to touch the eyelids, surrounding areas or other surfaces with the dropper tip of the bottle.
In order to prevent the drops from being absorbed via the nasal mucosa, particularly in newborn infants or children, the nasolacrimal ducts should be held closed for 2 to 3 minutes with the fingers after administering the drops. After cap is removed, if tamper evident snap collar is loose, remove before using the product.
If more than one topical ophthalmic medicinal product is being used, the medicinal products must be administered at least 5 minutes apart. Eye ointments should be administered last.
Q-MUMASA BABY (No preservative) single dose
Sodium chloride
Using for Ophthalmology and Otolaryngology symptoms
Q-MUMASA BABY multi dose
Sodium chloride 0.9%
Topical treatment of dry eye, eye irritation, eye pain
NOVOTANE ULTRA single dose
Polyethylene glycol/ Propylene glycol
Lubricate for eye and relief of dry eyes, eye irritation
Afenemi
Sodium hyaluronate
Lubricate for eye and relief of dry eyes, eye irritation.
Sodium chloride 0.9%
Ampoule 0.4 ml, 1ml
Single-dose ophthalmic
Treament of dry eye, eye irritation, eye pain...
Cleaning the eyes, nose and navel children daily
Mark tongue for children.
Adults (including the elderly) and Children:
Adequate solution should be used to irrigate the eye.
Sodium chloride 0.9%
Ampoule 3ml, 5ml, 10ml
Multi dose ophthalmic
Topical treatment of dry eye, eye irritation, eye pain...
Topical treatment of symptoms of nasal congestion, runny nose.
Clean the wound and scratches.
Used for infants.
Cleaning the eyes, nose and navel children daily
Mark tongue for children.
The usual dose is 1 or 2 drops placed in each eye when needed
Polyethylene glycol 400 4mg/ml;
Propylene glycol 3 mg/ml
Ampoule 0.4ml, 1ml
Single-dose ophthalmic
Lubricate for eye
Relief of dry eyes and eye irritation associated with deficient tear production.
- Shake well before using.
- Instill 1 or 2 drops in the affected eye(s) as needed.
Sodium hyaluronate 1.8 mg/ml.
Single-dose ophthalmic
Lubricate for eye
Relief of dry eyes and eye irritation associated with deficient tear production.
Twist off tab. Tilt the head backwards and position the tip of the container above the eye to be treated. Move the lower eyelid down with the forefinger of one hand. Press the container and one drop of AFENEMI will easily flow out. If not otherwise recommended, instill 1 or 2 drops of AFENEMI onto the eye as often as needed.
After blinking, the solution will disperse and form a transparent and long-lasting coating on the surface of the eye. AFENEMI may also be used while wearing contact lenses (rigid or soft).
DROPSTAR multi dose
Levofloxacin (as Levofloxacin hemihydrate)
Topical treatment of bacterial external ocular infections
TOBRAMESON single dose
Tobramycin/ Dexamethasone phosphate
Treat certain eye conditions due to inflammation or injury
Levofloxacin (as Levofloxacin hemihydrate) 5 mg/ml
Ampoule 3ml, 5ml, 10ml
Eye drops solution
Topical treatment of bacterial external ocular infections in patients
≥1 year of age caused by levofloxacin susceptible microorganisms
Posology
For all patients instil one to two drops in the affected eye(s) every two hours up to 8 times per day while awake for the first two days and then four times daily on days 3 through 5.
If different topical ocular medications are used concomitantly, at least a 15-minute interval is required between instillations.
The duration of treatment depends on the severity of the disorder and on the clinical and bacteriological course of infection. The usual treatment duration is 5 days.
Safety and efficacy in the treatment of corneal ulcer and ophthalmia neonatorum has not been established.
Use in the Elderly
No adjustment of dosage is required.
Paediatric population
The posology is the same in adults and children aged ≥1 year.
The safety and efficacy of Levofloxacin in children aged ≥1 year have been established.
Levofloxacin is not recommended for use in children below age 1 year due to a lack of data on safety and efficacy.
The safety and efficacy of Levofloxacin in children aged < 1 year have not yet been established.
No data are available.
Tobramycin (asTobramycin sulfate) 3 mg/ml
Dexamethasone phosphate (as
dexamethasone sodium phosphate) 1 mg/ml
Ampoule 0.4ml, 1ml
Single-dose ophthalmic
Prevention and treatment of inflammation and prevention of infection associated with cataract surgery in adults and children aged 2 years and older.
Adults:
One drop instilled into the conjunctival sac(s) every 4 to 6 hours while the patient is awake. During the initial 24 to 48 hours, the dosage may be increased to one drop every two hours while the patient is awake. Dosing should continue for 14 days not to exceed a maximum of 24 days. Frequency should be decreased gradually as warranted by improvement in clinical signs. Care should be taken not to discontinue therapy prematurely.
Use in the Elderly:
Clinical studies have indicated dosage modifications are not required for use in the elderly.
Paediatric population:
Drug may be used in children 2 years of age and older at the same dose as in adults.
TOBRAMESON multi dose
Tobramycin /Dexamethasone phosphate
Treat certain eye conditions due to inflammation or injury
DEXALEVO DROP multi dose
Levofloxacin/Dexamethasone phosphate
Treat certain eye conditions due to inflammation or injury
Tobramycin (asTobramycin sulfate) 3 mg/ml
Dexamethasone phosphate (as
dexamethasone sodium phosphate) 1 mg/ml
Ampoule 3ml, 5ml, 10ml
Eye drops solution
Prevention and treatment of inflammation and prevention of infection associated with cataract surgery in adults and children aged 2 years and older.
Adults:
One drop instilled into the conjunctival sac(s) every 4 to 6 hours while the patient is awake. During the initial 24 to 48 hours, the dosage may be increased to one drop every two hours while the patient is awake. Dosing should continue for 14 days not to exceed a maximum of 24 days. Frequency should be decreased gradually as warranted by improvement in clinical signs. Care should be taken not to discontinue therapy prematurely.
Use in the Elderly:
Clinical studies have indicated dosage modifications are not required for use in the elderly.
Paediatric population:
TOBRAMESON may be used in children 2 years of age and older at the same dose as in adults.
The safety and efficacy in children younger than 2 years of age have not been established, and no data is available.
Use in hepatic and renal impairment:
TOBRAMESON has not been studied in these patient populations
Shake the bottle well before use. To prevent contamination of the dropper tip and suspension, care should be taken not to touch the eyelids, surrounding areas, or other surfaces with the dropper tip of the bottle. Keep the bottle tightly closed when not in use. After cap is removed, if tamper evident snap collar is loose, remove before using product.
Gently closing the eyelid (s) and nasolacrimal occlusion for at least 1 minute after instillation is recommended. This may reduce the systemic absorption of medicinal products administered via the ocular route and result in a decrease in systemic side effects.
In case of concomitant therapy with other topical ophthalmic medicinal products, an interval of 5 minutes should be allowed between successive applications.
Eye ointments should be administered last.
Levofloxacin (as Levofloxacin hemihydrate) 5mg/ml; Dexamethasone phosphate (as Dexamethasone sodium phosphate) 1mg/ml
Ampoule 3ml, 5ml, 10 ml
Eye drops solution
Indicated for:
+ Steroid-responsive inflammatory ocular conditions (for which a corticosteroid is indicated and where bacterial infection or a risk of bacterial ocular infection exists)
+ Post-operative inflammation and any other ocular inflammation associated with infection.
- Day 1 and 2: 1-2 drops/time into eyes each 2 hours, 8 times/day.
- From day 3 to 7: 1-2 drops/time each 4 hours, 4 times/day.
- The number of drops should be reduced gradually when there are improvements in clinical signs. Should not stop treatment too soon.
To avoid contamination of the tip of the vial and drug solution, do not let the tip touch the eyelid, the area around the eye or any object.
- After opening the lid, the first drop should be removed before each use.
DEXAMOXI single dose
Moxifloxacine/ Dexamethasone phosphate
Treat certain eye conditions due to inflammation or injury
DEXAMOXI multi dose
Moxifloxacin/ Dexamethasone phosphate
Treat certain eye conditions due to inflammation or injury
Moxifloxacine (as moxifloxacin hydrochloride) 5 mg/ml Dexamethasone phosphate (as dexamethasone sodium phosphate) 1 mg/ml
Ampoule 0.4ml, 1ml
Single-dose ophthalmic
Indicated for:
+ Steroid-responsive inflammatory ocular conditions (for which a corticosteroid is indicated and where bacterial infection or a risk of bacterial ocular infection exists)
+ Post-operative inflammation and any other ocular inflammation
associated with infection.
- Prevention of inflammation and infection after eye surgery:
Medication into the eye surgery begins 1 day before surgery and lasts for another 15 days after surgery
- Cataract surgery:
1 drop / time x 4 times / day, drops immediately after surgery
- LASIK refractive surgery:
1 drop / time x 4 times / day, instill the medicine within 15 minutes after surgery.
- Eye infections caused by susceptible bacteria:
1 drop / time x 4 times / day, within 7 days or as directed by your doctor.
Moxifloxacine (as moxifloxacin hydrochloride) 5 mg/ml
Dexamethasone phosphate (as dexamethasone sodium phosphate) 1 mg/ml
Ampoule 2ml, 3ml, 5ml, 8ml, 10ml
Eye drops solution
Indicated for:
+ Steroid-responsive inflammatory ocular conditions (for which a corticosteroid is indicated and where bacterial infection or a risk of bacterial ocular infection exists)
+ Post-operative inflammation and any other ocular inflammation
associated with infection.
To prevent post-surgery ocular inflammation and infection, instill 1 drop 4 times per day in the eye to be operated, starting 1 day before the surgery and during 15 days after the surgery. In patients submitted to cataract surgery, instill the solution immediately after the surgery. In patients submitted to refractive surgery by LASIK, instill the solution within 15 minutes after the surgery.
In the ocular infections caused by susceptible organisms, instill 1 drop 4 times per day during 7 days, or as directed by the doctor.
Follow the doctor's instructions on the schedule, dose and duration of treatment. Do not discontinue treatment without consulting the doctor. Do not use outdated medicine. Observe the appearance of the medicine before using it.
To prevent contaminating the dropper tip and solution, care should be taken not to touch any surface with the dropper tip of the bottle.
FOR OCULAR USE ONLY. To prevent contamination of the dropper tip and solution, care must be taken not to touch the eyelids, surrounding areas or other surfaces with the dropper tip. Keep the bottle tightly closed when not in use. If the patient is using other eye drop or eye ointment medicines, leave at least 5 minutes between each medicine. Eye ointments should be administered last.
MOXIEYE single dose
Moxifloxacin (as Moxifloxacin hydrochloride)
Topical treatment of purulent bacterial conjunctivitis
MOXIEYE multi dose
Moxifloxacin (as Moxifloxacin hydrochloride)
Topical treatment of purulent bacterial conjunctivitis
Moxifloxacin (as Moxifloxacin hydrochloride) 5 mg/ml
Ampoule 0.4 ml, 1ml
Single-dose ophthalmic
Topical treatment of purulent bacterial conjunctivitis, caused by moxifloxacin susceptible strains
For ocular use only. Not for injection. MOXIEYE, solution should not be injected subconjunctivally or introduced directly into the anterior chamber of the eye.
Use in adults including the elderly (≥ 65 years)
The dose is one drop in the affected eye(s) 3 times a day.
The infection normally improves within 5 days and treatment should then be continued for a further 23 days. If no improvement is observed within 5 days of initiating therapy, the diagnosis and/or treatment should be reconsidered. The duration of treatment depends on the severity of the disorder and on the clinical and bacteriological course of infection.
Paediatric patients
No dosage adjustment is necessary.
Use in hepatic and renal impairment No dosage adjustment is necessary.
To prevent contamination of the dropper tip and solution, care must be taken not to touch the eyelids, surrounding areas or other surfaces with the dropper tip of the bottle.
In order to prevent the drops from being absorbed via the nasal mucosa, particularly in newborn infants or children, the nasolacrimal ducts should be held closed for 2 to 3 minutes with the fingers after administering the drops. After cap is removed, if tamper evident snap collar is loose, remove before using the product.
If more than one topical ophthalmic medicinal product is being used, the medicinal products must be administered at least 5 minutes apart. Eye ointments should be administered last.
Moxifloxacin (as Moxifloxacin hydrochloride) 5 mg/ml
Ampoule 2ml, 3ml, 5ml, 10ml
Eye drops solution
Topical treatment of purulent bacterial conjunctivitis, caused by moxifloxacin susceptible strains
For ocular use only. Not for injection. MOXIEYE, solution should not be injected subconjunctivally or introduced directly into the anterior chamber of the eye.
Use in adults including the elderly (≥ 65 years)
The dose is one drop in the affected eye(s) 3 times a day.
The infection normally improves within 5 days and treatment should then be continued for a further 23 days. If no improvement is observed within 5 days of initiating therapy, the diagnosis and/or treatment should be reconsidered. The duration of treatment depends on the severity of the disorder and on the clinical and bacteriological course of infection.
Paediatric patients
No dosage adjustment is necessary.
Use in hepatic and renal impairment No dosage adjustment is necessary.
To prevent contamination of the dropper tip and solution, care must be taken not to touch the eyelids, surrounding areas or other surfaces with the dropper tip of the bottle.
In order to prevent the drops from being absorbed via the nasal mucosa, particularly in newborn infants or children, the nasolacrimal ducts should be held closed for 2 to 3 minutes with the fingers after administering the drops. After cap is removed, if tamper evident snap collar is loose, remove before using the product.
If more than one topical ophthalmic medicinal product is being used, the medicinal products must be administered at least 5 minutes apart. Eye ointments should be administered last.
Q-MUMASA BABY (No preservative) single dose
Sodium chloride
Using for Ophthalmology and Otolaryngology symptoms
Q-MUMASA BABY multi dose
Sodium chloride 0.9%
Topical treatment of dry eye, eye irritation, eye pain
Sodium chloride 0.9%
Ampoule 0.4 ml, 1ml
Single-dose ophthalmic
Treament of dry eye, eye irritation, eye pain...
Cleaning the eyes, nose and navel children daily
Mark tongue for children.
Adults (including the elderly) and Children:
Adequate solution should be used to irrigate the eye.
Sodium chloride 0.9%
Ampoule 3ml, 5ml, 10ml
Multi dose ophthalmic
Topical treatment of dry eye, eye irritation, eye pain...
Topical treatment of symptoms of nasal congestion, runny nose.
Clean the wound and scratches.
Used for infants.
Cleaning the eyes, nose and navel children daily
Mark tongue for children.
The usual dose is 1 or 2 drops placed in each eye when needed
NOVOTANE ULTRA single dose
Polyethylene glycol/ Propylene glycol
Lubricate for eye and relief of dry eyes, eye irritation
Afenemi
Sodium hyaluronate
Lubricate for eye and relief of dry eyes, eye irritation.
Polyethylene glycol 400 4mg/ml;
Propylene glycol 3 mg/ml
Ampoule 0.4ml, 1ml
Single-dose ophthalmic
Lubricate for eye
Relief of dry eyes and eye irritation associated with deficient tear production.
- Shake well before using.
- Instill 1 or 2 drops in the affected eye(s) as needed.
Sodium hyaluronate 1.8 mg/ml.
Single-dose ophthalmic
Lubricate for eye
Relief of dry eyes and eye irritation associated with deficient tear production.
Twist off tab. Tilt the head backwards and position the tip of the container above the eye to be treated. Move the lower eyelid down with the forefinger of one hand. Press the container and one drop of AFENEMI will easily flow out. If not otherwise recommended, instill 1 or 2 drops of AFENEMI onto the eye as often as needed.
After blinking, the solution will disperse and form a transparent and long-lasting coating on the surface of the eye. AFENEMI may also be used while wearing contact lenses (rigid or soft).